Agenus | AGEN - PE Price to Earnings


Agenus reported 17.82 in PE Price to Earnings for its fiscal quarter ending in June of 2022.





Pe Change Date
AbbVie 23.03 1 Mar/2026
Amgen 19.84 5.47 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
CSL 16.16 9.59 Dec/2025
Eli Lilly 40.27 0.06 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 15.35 0.51 Mar/2026
Intrexon 7.54 221.44 Dec/2021
J&J 24.53 0.91 Mar/2026
Jiangsu Hengrui 46.42 5.23 Mar/2026
Merck 12.74 7.82 Mar/2026
Merck 16.52 2.6 Mar/2026
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Novartis 20.17 2.32 Mar/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 9.32 5.16 Mar/2026
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 24.89 20.41 Mar/2026